Lars Masanneck

ORCID: 0000-0003-2496-1415
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Myasthenia Gravis and Thymoma
  • Health and Medical Studies
  • Artificial Intelligence in Healthcare and Education
  • COVID-19 diagnosis using AI
  • Biomedical Text Mining and Ontologies
  • Digital Mental Health Interventions
  • Hereditary Neurological Disorders
  • Mechanical Circulatory Support Devices
  • Sphingolipid Metabolism and Signaling
  • Cytokine Signaling Pathways and Interactions
  • Meta-analysis and systematic reviews
  • interferon and immune responses
  • Psychiatric care and mental health services
  • Eosinophilic Disorders and Syndromes
  • Machine Learning in Healthcare
  • CNS Lymphoma Diagnosis and Treatment
  • T-cell and B-cell Immunology
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Immunotherapy and Immune Responses
  • Inflammatory Biomarkers in Disease Prognosis
  • Viral Infections and Immunology Research
  • Immune Cell Function and Interaction
  • RNA regulation and disease

Düsseldorf University Hospital
2021-2025

Heinrich Heine University Düsseldorf
2021-2025

Hasso Plattner Institute
2022-2024

University of Potsdam
2022-2024

University Hospital Münster
2020-2021

Digital Health Technologies (DHTs) such as connected sensors offer particular promise for improving data collection and patient empowerment in neurology research care. This study analyzed the recent evolution of use DHTs trials registered on ClinicalTrials.gov four chronic neurological disorders: epilepsy, multiple sclerosis, Alzheimer's, Parkinson's disease. We document growth both more established digital measures (e.g., motor function) novel speech) over years, highlighting contexts key trends.

10.1038/s41746-023-00767-1 article EN cc-by npj Digital Medicine 2023-02-10

Background Large language models (LLMs) have demonstrated impressive performances in various medical domains, prompting an exploration of their potential utility within the high-demand setting emergency department (ED) triage. This study evaluated triage proficiency different LLMs and ChatGPT, LLM-based chatbot, compared to professionally trained ED staff untrained personnel. We further explored whether LLM responses could guide effective Objective aimed assess efficacy associated product...

10.2196/53297 article EN cc-by Journal of Medical Internet Research 2024-06-14

Abstract The 2019 German Digital Healthcare Act introduced the Health Application program, known in as ‘Digitale Gesundheitsanwendungen’ (DiGA). program has established a pioneering model for integrating Therapeutics (DTx) into healthcare system with scalable and effective reimbursement strategies. To date, continuous upward trend enabled by this framework resulted more than 374,000 DiGA prescriptions, increasingly cementing its role system. This perspective provides synthesis of program’s...

10.1038/s41746-024-01137-1 article EN cc-by npj Digital Medicine 2024-05-24

Ocrelizumab is a B cell-depleting drug widely used in relapsing-remitting multiple sclerosis (RRMS) and primary-progressive MS. In RRMS, it becoming increasingly apparent that accumulation of disability not only manifests as relapse-associated worsening (RAW) but also progression independent relapse activity (PIRA) throughout the disease course. This study's objective was to investigate role PIRA RRMS patients treated with ocrelizumab. We performed single-center, retrospective,...

10.1038/s41598-023-40940-w article EN cc-by Scientific Reports 2023-09-11

Introduction: The efficacy of anti-CD20 antibodies has significantly contributed to advancing our understanding disease pathogenesis and improved treatment outcomes in relapsing-remitting multiple sclerosis (RRMS). A comprehensive analysis the peripheral immune cell profile, combined with prospective clinical characterization, RRMS patients treated ocrelizumab (OCR) or ofatumumab (OFA) was performed further understand reconstitution following B-cell depletion. Methods: REBELLION-MS is a...

10.3390/cells14070552 article EN cc-by Cells 2025-04-06

Digital therapeutics (DTx), evidence-based software interventions for preventing, managing, or treating medical disorders, have rapidly evolved with healthcare's shift toward online, patient-centric solutions. This study scrutinizes DTx clinical trials from 2005 to 2022, analyzing their growth, funding, underlying specialties, and other R&D characteristics, using ClinicalTrials.gov data. Our analysis includes categorized via the ICD-11 system, covering active, recruiting, completed studies...

10.1002/cpt.3260 article EN cc-by-nc Clinical Pharmacology & Therapeutics 2024-04-02

Abstract Background Immune dysregulation is a hallmark of autoimmune diseases the central nervous system (CNS), characterized by an excessive immune response, and primary CNS tumors (pCNS-tumors) showing highly immunosuppressive parenchymal microenvironment. Methods Aiming to provide novel insights into pathogenesis autoimmunity cerebral tumor immunity, we analyzed peripheral blood (PB) cerebrospinal fluid (CSF) 81 limbic encephalitis (ALE), 148 relapsing–remitting multiple sclerosis (RRMS),...

10.1186/s12974-024-03269-3 article EN cc-by Journal of Neuroinflammation 2024-11-04

Effectively managing evidence-based information is increasingly challenging. This study tested large language models (LLMs), including document- and online-enabled retrieval-augmented generation (RAG) systems, using 13 recent neurology guidelines across 130 questions. Results showed substantial variability. RAG improved accuracy compared to base but still produced potentially harmful answers. RAG-based systems performed worse on case-based than knowledge-based Further refinement regulation...

10.1038/s41746-025-01536-y article EN cc-by npj Digital Medicine 2025-03-04

Due to the growing complexity in monitoring and treatment of many disorders, disease-specific care research networks offer patients certified healthcare. However, networks' ability provide health services close patients' homes usually remains vague. Digital Health Technologies (DHTs) help better care, especially if implemented a targeted manner regions undersupplied by specialised networks. Therefore, we used car travel time-based isochrone approach identify gaps using example...

10.1177/20552076231152989 article EN cc-by-nc-nd Digital Health 2023-01-01

Cyclic GMP-AMP-synthase is a sensor of endogenous nucleic acids, which subsequently elicits stimulator interferon genes (STING)-dependent type I (IFN) response defending us against viruses and other intracellular pathogens. This pathway can drive pathological inflammation, as documented for interferonopathies. In contrast, specific STING activation subsequent IFN-β release have shown beneficial effects on experimental autoimmune encephalomyelitis (EAE) model multiple sclerosis (MS). Although...

10.3390/ijms21239249 article EN International Journal of Molecular Sciences 2020-12-04

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an disease affecting the peripheral nerves and most frequent autoimmune polyneuropathy. Given lack of established biomarkers or risk factors for development CIDP patients' treatment response, this research effort seeks to identify potential clinical that may influence progression overall efficacy.

10.1007/s00415-024-12548-1 article EN cc-by Journal of Neurology 2024-07-11

The medical care of patients with myositis is a great challenge in clinical practice. This due to the rarity these disease, complexity diagnosis and management as well lack systematic analyses.Therefore, aim this project was obtain an overview current Germany evaluate epidemiological trends recent years.In collaboration BARMER Insurance, retrospective analysis outpatient inpatient data from average approximately 8.7 million insured between January 2005 December 2019 performed using ICD-10...

10.1186/s42466-022-00226-4 article EN cc-by Neurological Research and Practice 2022-12-29

Abstract Introduction Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the most common immune neuropathies leading to severe impairments in daily life. Current treatment options include intravenous immunoglobulins (IVIG), which are administered at intervals 4–12 weeks. Determination individual challenging since existing clinical scores lack sensitivity objectify small, partially fluctuating deficits patients. End-of-dose phenomena described by patients, manifested increased...

10.1186/s42466-023-00267-3 article EN cc-by Neurological Research and Practice 2023-08-24

Aside from the established immune-mediated etiology of multiple sclerosis (MS), compelling evidence implicates platelets as important players in disease pathogenesis. Specifically, numerous studies have highlighted that activated promote central nervous system (CNS)-directed adaptive immune response early course. Platelets, therefore, present a novel opportunity for modulating neuroinflammatory process characterizes MS. We hypothesized well-known antiplatelet agent acetylsalicylic acid (ASA)...

10.3390/ijms22189915 article EN International Journal of Molecular Sciences 2021-09-14

Immune-mediated peripheral nervous system (PNS) disorders pose diagnostic and therapeutic challenges, necessitating collaborative, patient-centered care. Limited access to specialized centers leads delayed diagnosis care, as seen during the COVID-19 pandemic. To address these accessible care is crucial. On-site support plays a vital role in advising assisting patients caregivers, enabling multidisciplinary for PNS diseases.

10.1212/cpj.0000000000200295 article EN cc-by-nc-nd Neurology Clinical Practice 2024-04-15

Recent years have seen a rapid growth in the number of online health communities targeted at patients with long-term conditions. Myasthenia Gravis (MG) is rare neurological disease for which such not been analysed before. The aim this study was to better understand needs MG population through collation and categorisation questions that users social media were asking fellow on these platforms.

10.3389/fneur.2024.1474347 article EN cc-by Frontiers in Neurology 2024-09-27

<sec> <title>BACKGROUND</title> Large language models (LLMs) have demonstrated impressive performances in various medical domains, prompting an exploration of their potential utility within the high-demand setting emergency department (ED) triage. This study evaluated triage proficiency different LLMs and ChatGPT, LLM-based chatbot, compared to professionally trained ED staff untrained personnel. We further explored whether LLM responses could guide effective </sec> <title>OBJECTIVE</title>...

10.2196/preprints.53297 preprint EN 2023-10-02
Coming Soon ...